Literature DB >> 16794247

Low-grade gliomas in adults.

Jeanine T Grier1, Tracy Batchelor.   

Abstract

Low-grade gliomas are a heterogeneous group of neoplasms usually encountered in younger patient populations. These tumors represent a unique challenge because most patients will survive a decade or more and may be at a higher risk for treatment-related complications. Clinical observations over the years have identified a subset of low-grade gliomas that tends to manifest more aggressive clinical behavior and require earlier, more aggressive intervention. Clinical and molecular parameters may allow better assessment of prognosis and application of risk-adjusted management strategies that may include resection, radiation, or chemotherapy. Improved methods of long-term cognitive and functional assessment are desperately needed in this patient population.

Entities:  

Mesh:

Year:  2006        PMID: 16794247     DOI: 10.1634/theoncologist.11-6-681

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  56 in total

1.  Role of diffusion tensor magnetic resonance tractography in predicting the extent of resection in glioma surgery.

Authors:  Antonella Castellano; Lorenzo Bello; Caterina Michelozzi; Marcello Gallucci; Enrica Fava; Antonella Iadanza; Marco Riva; Giuseppe Casaceli; Andrea Falini
Journal:  Neuro Oncol       Date:  2011-10-20       Impact factor: 12.300

Review 2.  Gamma Knife treatment of low-grade gliomas in children.

Authors:  Murat Şakir Ekşi; Baran Yılmaz; Akın Akakın; Zafer Orkun Toktaş; Ahmet Cemil Kaur; Mustafa Kemal Demir; Türker Kılıç
Journal:  Childs Nerv Syst       Date:  2015-07-15       Impact factor: 1.475

3.  G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity.

Authors:  Chin-An Yang; Hsi-Yuan Huang; Cheng-Li Lin; Jan-Gowth Chang
Journal:  J Neurooncol       Date:  2018-05-29       Impact factor: 4.130

4.  Impact of WHO 2016 update of brain tumor classification, molecular markers and clinical outcomes in pleomorphic xanthoastrocytoma.

Authors:  Raees Tonse; Tejpal Gupta; Sridhar Epari; Jayant Goda Shastri; Mamta Gurav; Nazia Bano; Rakesh Jalali
Journal:  J Neurooncol       Date:  2017-11-16       Impact factor: 4.130

5.  Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424.

Authors:  Barbara J Fisher; Chen Hu; David R Macdonald; Glenn J Lesser; Stephen W Coons; David G Brachman; Samuel Ryu; Maria Werner-Wasik; Jean-Paul Bahary; Junfeng Liu; Arnab Chakravarti; Minesh Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-01-30       Impact factor: 7.038

6.  Generalized q-sampling imaging fiber tractography reveals displacement and infiltration of fiber tracts in low-grade gliomas.

Authors:  Pinar Celtikci; David T Fernandes-Cabral; Fang-Cheng Yeh; Sandip S Panesar; Juan C Fernandez-Miranda
Journal:  Neuroradiology       Date:  2018-01-25       Impact factor: 2.804

7.  Non-additive and epistatic effects of HLA polymorphisms contributing to risk of adult glioma.

Authors:  Chenan Zhang; Adam J de Smith; Ivan V Smirnov; John K Wiencke; Joseph L Wiemels; John S Witte; Kyle M Walsh
Journal:  J Neurooncol       Date:  2017-07-18       Impact factor: 4.130

8.  Clinical prognostic factors of adjuvant radiation therapy for low-grade gliomas: results of 10 years survival.

Authors:  Vildan Kaya; Melek Gamze Aksu; Aylin Fidan Korcum; Beyza Ozdemir; Yiğit Ceçen; Bora Sindir; Mine Genç
Journal:  Int J Clin Exp Med       Date:  2014-05-15

Review 9.  Current trends in intraoperative optical imaging for functional brain mapping and delineation of lesions of language cortex.

Authors:  Neal Prakash; Falk Uhlemann; Sameer A Sheth; Susan Bookheimer; Neil Martin; Arthur W Toga
Journal:  Neuroimage       Date:  2008-08-22       Impact factor: 6.556

10.  Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes.

Authors:  K E Emblem; D Scheie; P Due-Tonnessen; B Nedregaard; T Nome; J K Hald; K Beiske; T R Meling; A Bjornerud
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.